OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
After his PhD on thymocyte development at the MRC National Institute for Medical Research (NIMR) in London, Andreas Wack moved to the research institute of Novartis Vaccines in Siena, Italy, where he worked on the modulation of human T and NK cell function by the hepatitis C virus, human dendritic cell subsets and their crosstalk, the mechanism of action of vaccine adjuvants, and next generation influenza vaccines. Since 2009 he is back at the NIMR, now Francis Crick Institute, where his group studies the responses of airway epithelia and innate immune cells to influenza infection and to influenza-bacterial co-infection. His lab aims to identify determinants of immunopathology and protection and has assessed unique and redundant roles of type I and type III interferons in influenza. A second focus of his group is airway epithelial cell differentiation, a process that has to be efficient and balanced to guarantee timely repair of lung tissue damage during infection.
